Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Fish and Richardson
Harvard Business School
Chinese Patent Office

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040541

« Back to Dashboard
NDA 040541 describes SOTRADECOL, which is a drug marketed by Mylan Institutional and Elkins Sinn and is included in two NDAs. It is available from one supplier. Additional details are available on the SOTRADECOL profile page.

The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There are one thousand three hundred and ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.

Summary for NDA: 040541

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 040541

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
sodium tetradecyl sulfate
INJECTABLE;INJECTION 040541 ANDA Mylan Institutional LLC 67457-162 67457-162-02 5 VIAL, GLASS in 1 CARTON (67457-162-02) > 2 mL in 1 VIAL, GLASS (67457-162-00)
sodium tetradecyl sulfate
INJECTABLE;INJECTION 040541 ANDA Mylan Institutional LLC 67457-163 67457-163-02 5 VIAL, GLASS in 1 CARTON (67457-163-02) > 2 mL in 1 VIAL, GLASS (67457-163-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/2ML (10MG/ML)
Approval Date:Nov 12, 2004TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength60MG/2ML (30MG/ML)
Approval Date:Nov 12, 2004TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus